Request for Proposals (RFP) on Clinical Site Monitoring and Data Management Services for The Biomarkers Consortium Kidney Safety Project

Request for Proposals (RFP) on Clinical Site Monitoring and Data Management Services for The Biomarkers Consortium Kidney Safety Project The National Institute of Mental Health is delighted to be a partner on the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ). The Foundation for the National Institutes of Health (NIH) is requesting information on Phase 2-ready compounds with a compelling biological hypothesis to address biological or clinical outcomes in the earliest stages of schizophrenia. This high-level overview is requested to inform on the selection of compounds for use in a biomarker focused proof of principle trial(s). The AMP SCZ project team looks forward to receiving your proposals and submissions by February 3, 2023!